川宁生物

- 301301

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2025  2024  2023  2022  2021  2020  2019  2018 
川宁生物(301301) 利润表
单位:万元
报表日期2025-09-302025-06-302025-03-312024-12-312024-09-30
一、营业总收入343,598.43234,858.40129,694.96575,830.77445,626.56
营业收入343,598.43234,858.40129,694.96575,830.77445,626.56
二、营业总成本265,055.80175,302.6894,759.46405,975.58315,449.44
营业成本230,897.69150,626.4181,275.61366,309.21285,999.02
营业税金及附加5,564.073,963.682,159.957,970.236,749.73
销售费用1,914.281,351.91795.172,553.581,957.02
管理费用15,775.8111,013.485,753.0116,533.9112,090.72
财务费用2,540.391,583.83766.304,835.654,246.33
研发费用8,363.566,763.374,009.407,773.004,406.61
资产减值损失----------
公允价值变动收益-22.640.44--3.1564.45
投资收益-202.52-70.28-16.09-919.52-715.85
其中:对联营企业和合营企业的投资收益-233.31-145.24-65.92-77.93-36.54
汇兑收益----------
三、营业利润76,793.6257,543.1235,333.18168,776.29129,471.55
加:营业外收入17.9716.970.44110.28107.27
减:营业外支出1,634.111,609.77333.351,377.391,786.61
其中:非流动资产处置损失----------
四、利润总额75,177.4855,950.3235,000.27167,509.18127,792.21
减:所得税费用14,087.0810,492.756,179.6127,474.1620,196.50
五、净利润61,090.3945,457.5728,820.66140,035.02107,595.71
归属于母公司所有者的净利润61,139.3245,485.8328,821.85140,032.41107,591.85
少数股东损益-48.92-28.26-1.192.613.85
六、每股收益
基本每股收益(元/股)0.27000.20000.13000.63000.4800
稀释每股收益(元/股)0.27000.20000.13000.63000.4800
七、其他综合收益-------9.93--
八、综合收益总额61,090.3945,457.5728,820.66140,025.09107,595.71
归属于母公司所有者的综合收益总额61,139.3245,485.8328,821.85140,022.48107,591.85
归属于少数股东的综合收益总额-48.92-28.26-1.192.613.85
下载全部历史数据到excel中 返回页顶